Showing results (161-170 of 364) with videos related to
Sort By:
Pageof 37
Developmental Pharmacology and Therapeutics|January 1, 1980
Factors affecting theophylline pharmacokinetics in premature infants with apneaD M Hilligoss, W J Jusko, J R Koup, et al.The American Journal of Gastroenterology|March 1, 1980
Bioavailability of hydrocortisone retention enemas in normal subjectsJ J Lima, J Giller, J J Mackichan, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1989
Pharmacokinetics and pharmacodynamics of prednisolone in obese ratsA I Nichols, R D'Ambrosio, N A Pyszczynski, et al.Drug Intelligence & Clinical Pharmacy|July 1, 1983
Procainamide disposition in obesityP B Christoff, D R Conti, C Naylor, et al.Journal of Clinical Pharmacology|April 17, 2001
Clinical pharmacokinetics and pharmacodynamics of a new squalene synthase inhibitor, BMS-188494, in healthy volunteersA Sharma, P H Slugg, J L Hammett, et al.Antimicrobial Agents and Chemotherapy|March 1, 1982
Dose-dependent pharmacokinetics of mezlocillin in relation to renal impairmentA Mangione, F D Boudinot, R M Schultz, et al.Research Communications in Chemical Pathology and Pharmacology|January 1, 1975
Digoxin concentrations in serum and salivaW J Jusko, L Gerbracht, L H Golden, et al.Journal of Clinical Pharmacology|October 1, 1996
Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple dosesG M Ferron, M Rochdi, W J Jusko, et al.Clinical Pharmacology and Therapeutics|April 1, 1978
Theophylline disposition in obesityP Gal, W J Jusko, A M Yurchak, et al.Antimicrobial Agents and Chemotherapy|November 1, 1981
Mezlocillin disposition in chronic hemodialysis patientsD M Janicke, A Mangione, R W Schultz, et al.Pageof 37